United Kingdom (UK) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

October 2023 | 50 pages | ID: UA3CD3E6BAC3EN
MarketLine

Abstracts

United Kingdom (UK) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Summary

Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The UK pharmaceuticals market had total revenues of $31.7 billion in 2022, representing a compound annual growth rate (CAGR) of 4.8% between 2017 and 2022.
• 0
• According to in-house research, in 2022, the UK accounted for 8.9% of the European pharmaceuticals market. The growth in the pharmaceuticals market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in the UK stood at 9.5% of total health spending in 2021.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United Kingdom
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United Kingdom
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

• What was the size of the United Kingdom pharmaceuticals market by value in 2022?
• What will be the size of the United Kingdom pharmaceuticals market in 2027?
• What factors are affecting the strength of competition in the United Kingdom pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitors in the United Kingdom's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?

8 COMPANY PROFILES

8.1. Novartis AG
8.2. GSK plc.
8.3. AstraZeneca PLC
8.4. Pfizer Inc.

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: United Kingdom pharmaceuticals market value: $ billion, 2017-22
Table 2: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: United Kingdom pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Novartis AG: key facts
Table 5: Novartis AG: Annual Financial Ratios
Table 6: Novartis AG: Key Employees
Table 7: Novartis AG: Key Employees Continued
Table 8: GSK plc.: key facts
Table 9: GSK plc.: Annual Financial Ratios
Table 10: GSK plc.: Key Employees
Table 11: GSK plc.: Key Employees Continued
Table 12: AstraZeneca PLC: key facts
Table 13: AstraZeneca PLC: Annual Financial Ratios
Table 14: AstraZeneca PLC: Key Employees
Table 15: AstraZeneca PLC: Key Employees Continued
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: Annual Financial Ratios
Table 18: Pfizer Inc.: Key Employees
Table 19: Pfizer Inc.: Key Employees Continued
Table 20: United Kingdom size of population (million), 2018-22
Table 21: United Kingdom gdp (constant 2005 prices, $ billion), 2018-22
Table 22: United Kingdom gdp (current prices, $ billion), 2018-22
Table 23: United Kingdom inflation, 2018-22
Table 24: United Kingdom consumer price index (absolute), 2018-22
Table 25: United Kingdom exchange rate, 2018-22

List Of Figures

LIST OF FIGURES

Figure 1: United Kingdom pharmaceuticals market value: $ billion, 2017-22
Figure 2: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: United Kingdom pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2022